Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2012
12/05/2012EP2528895A2 Trypsin-like serine protease inhibitors, and their preparation and use
12/05/2012EP2528606A1 Quinazoline-based t cell proliferation inhibitors
12/05/2012EP2528441A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
12/05/2012CN102812017A Pyrazine derivatives
12/05/2012CN102812008A Therapeutic agent or preventive agent for urine collection disorder
12/05/2012CN102812006A New anti-malarial agents
12/05/2012CN102812005A Inhibitors of beta-secretase
12/05/2012CN102812004A Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using the same
12/05/2012CN102812003A Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Disordersas As Agonists Of G- Protein Coupled Receptor 43 (GPR43)
12/05/2012CN102807562A Method for preparing rupatadine and salt thereof
12/05/2012CN102807561A S-omeprazole aluminum salt and preparation method and application thereof
12/05/2012CN102807560A New method for synthesizing esomeprazole through asymmetrically catalytic oxidation
12/05/2012CN102807559A Method for synthesizing optically pure substituted sulfoxide compound
12/05/2012CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor
12/05/2012CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
12/05/2012CN101768151B 2-(2-pyridyl)-8-sulfonamidoquinoline derivative, synthesis method and application thereof
12/05/2012CN101535258B Ether derivatives dual modulators of the 5-ht2a and d3 receptors
12/05/2012CN101481515B Preparation of reactive dye
12/05/2012CN101481514B Preparation of yellow reactive dye
12/05/2012CN101379055B Substituted quinolones III
12/05/2012CN101356156B Aspartic protease inhibitors
12/05/2012CN101258141B N-thio-anthranilamid compounds and their use as pesticides
12/05/2012CN101255131B Heterocyclic derivatives as opioid modulators
12/05/2012CN101184749B Spirocyclic heterocyclic derivatives and methods of their use
12/05/2012CN101098854B Bivalent linkers and conjugates thereof
12/05/2012CN101045725B Malate and multicrystal object of some quinolone compound
12/05/2012CN101023070B Method for the production of dihydropteridinones
12/04/2012US8324403 Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime
12/04/2012US8324391 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
12/04/2012US8324390 Tetrazole-substituted anthranilamides as pesticides
12/04/2012US8324389 Solid forms of a Raf kinase inhibitor
12/04/2012US8324385 Diacylglycerol acyltransferase inhibitors
12/04/2012US8324384 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/04/2012US8324380 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
12/04/2012US8324265 Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
12/04/2012US8324252 e.g. 6-(5-Cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoro-2-(1-(4-fluorophenyl)ethylamino) nicotinonitrile; tropomyosin-related kinases (Trk's) inhibitor; anticarcinogenic agent; hormone related cancer, leukemia; antiinflammatory agent; arthritis, restenosis; autoimmune diseases
12/04/2012US8324248 Piperidine derivatives as NK3 receptor antagonists
12/04/2012US8324245 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/04/2012US8324235 Heterocyclic spiro-compounds
12/04/2012US8324234 Method for inhibiting melanin production and whitening skin with pyrimidylpyrazole compounds or pharmaceutically acceptable salts thereof
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324205 Quinazoline derivatives as kinase inhibitors
12/04/2012US8324203 Azadecalin glucocorticoid receptor modulators
12/04/2012US8324200 Compositions and methods for inhibition of the JAK pathway
12/04/2012US8324199 Pyridazine derivatives as factor xia inhibitors
12/04/2012US8324198 Monocarbams
12/04/2012US8324186 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2
12/04/2012US8324133 Fungicide 2-pyridyl-methylene-carboxamide derivatives
12/04/2012US8324125 Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst
12/04/2012CA2674543C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/04/2012CA2622760C Cyclopropyl amines as modulators of the histamine h3 receptor
12/04/2012CA2618362C Hindered cyclic polyamines and their salts for acid gas scrubbing process
12/04/2012CA2567003C Pyrimidine derivatives which are antagonists of the vitronectin receptor
12/04/2012CA2518932C 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/2012
11/29/2012WO2012162635A1 Metabotropic glutamate receptors 5 modulators and methods of use thereof
11/29/2012WO2012162254A1 Inhibitors of lrrk2 kinase activity
11/29/2012WO2012161877A1 Pyridine-and pyrazine derivatives
11/29/2012WO2012161133A1 Substituted pyridazine compound and agricultural or horticultrual bactericidal agent
11/29/2012WO2012161071A1 Nitrogenated heterocyclic compound and agricultural or horticultural bactericidal agent
11/29/2012WO2012160447A1 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
11/29/2012WO2012160034A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012WO2012159959A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/29/2012WO2012159662A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012134206A3 Process for the preparation of anhydrous aripiprazole crystal form ii
11/29/2012WO2012102937A3 Benz imidazole compounds that expand hematopoietic stem cells
11/29/2012US20120302746 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302608 Novel Imidazole Derivatives Useful for the Treatment of Arthritis
11/29/2012US20120302605 3-deutero-pomalidomide
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302582 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302543 Compounds for the Treatment of Neurological Disorders
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120298975 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/29/2012CA2837312A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof
11/29/2012CA2837199A1 Inhibitors of lrrk2 kinase activity
11/29/2012CA2837027A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012CA2836084A1 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
11/29/2012CA2833192A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/29/2012CA2832605A1 Pyridine-and pyrazine derivatives
11/28/2012EP2527340A1 Piperazine compound having a pgds inhibitory effect
11/28/2012EP2527339A1 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
11/28/2012EP2527338A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
11/28/2012EP2527337A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
11/28/2012EP2527336A1 Deuterated analogues of cilostazol
11/28/2012EP2527335A1 Triazole compounds as anti-inflammatory agents
11/28/2012EP2527330A1 Inhibitors of the hedgehog pathway
11/28/2012EP2527328A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2526098A1 Nitrogen-containing heteroaryl derivatives
11/28/2012EP2526097A1 Pyrazine derivatives
11/28/2012EP2526096A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
11/28/2012EP2526095A1 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 1080